Voiglim M1

Voiglim M1 by Voithea Healthcare is a trusted anti-diabetic formulation combining Glimepiride 1mg and Metformin 500mg to provide effective glycemic control for individuals with type 2 diabetes. Glimepiride works by stimulating insulin release from pancreatic beta cells, while Metformin improves insulin sensitivity and reduces hepatic glucose production, making this combination ideal for managing elevated blood sugar levels efficiently.

Designed for patients needing dual therapy, Voiglim M1 supports long-term blood glucose regulation while helping minimize the risk of diabetes-related complications. With Voithea Healthcare’s dedication to quality and affordability, this combination therapy helps patients maintain better control over their diabetes, contributing to improved overall metabolic health and quality of life.